Continuing review of an approved and ongoing protocol
Must be conducted by a convened IRB.
Is limited to review of unanticipated problems.
Must occur within 12 months of the approval date.
Is not required unless additional risks have been identified.
Answer: Must occur within 12 months of the approval date.